Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Richard Harrigan

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2010
HIV drug resistance over the long haulP Richard Harrigan
AIDS (London, England)|November 26, 2019
Narrowing down the causes of failure of tenofovir (only) for preexposure prophylaxisHope R Lapointe, P Richard Harrigan
AIDS (London, England)|November 25, 2010
Genotypic tropism testing: evidence-based or leap of faith?P Richard Harrigan, Anna Maria Geretti
AIDS Reviews|July 20, 2006
The impact of human genetic variation on HIV disease in the era of HAARTZabrina L Brumme, P Richard Harrigan
The Journal of Infectious Diseases|June 13, 2020
Human Immunodeficiency Virus Phylogenetics in the United States-and ElsewhereHope R Lapointe, P Richard Harrigan
The Journal of Infectious Diseases|April 20, 2005
No inherent association between minor mutations in HIV protease at baseline and selection of the L90M mutation at the time of the first virological failureChanson J Brumme, P Richard Harrigan
Antimicrobial Agents and Chemotherapy|February 19, 2002
Extent of cross-resistance between agents used to treat human immunodeficiency virus type 1 infection in clinically derived isolatesP Richard Harrigan, Brendan A Larder
AIDS Reviews|August 31, 2004
2004: which HIV-1 drug resistance mutations are common in clinical practice?Peter K Cheung, Brian Wynhoven, P Richard Harrigan
AIDS Reviews|September 30, 2008
HIV coreceptor phenotyping in the clinical settingAndrew J Low, Luke C Swenson, P Richard Harrigan
Expert Opinion on Medical Diagnostics|March 15, 2013
Trofile HIV co-receptor usage assayAndrew J Low, Rachel A McGovern, P Richard Harrigan
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2010
HIV drug resistance over the long haulP Richard Harrigan
AIDS (London, England)|November 26, 2019
Narrowing down the causes of failure of tenofovir (only) for preexposure prophylaxisHope R Lapointe, P Richard Harrigan
AIDS (London, England)|November 25, 2010
Genotypic tropism testing: evidence-based or leap of faith?P Richard Harrigan, Anna Maria Geretti
AIDS Reviews|July 20, 2006
The impact of human genetic variation on HIV disease in the era of HAARTZabrina L Brumme, P Richard Harrigan
The Journal of Infectious Diseases|June 13, 2020
Human Immunodeficiency Virus Phylogenetics in the United States-and ElsewhereHope R Lapointe, P Richard Harrigan
The Journal of Infectious Diseases|April 20, 2005
No inherent association between minor mutations in HIV protease at baseline and selection of the L90M mutation at the time of the first virological failureChanson J Brumme, P Richard Harrigan
Antimicrobial Agents and Chemotherapy|February 19, 2002
Extent of cross-resistance between agents used to treat human immunodeficiency virus type 1 infection in clinically derived isolatesP Richard Harrigan, Brendan A Larder
AIDS Reviews|August 31, 2004
2004: which HIV-1 drug resistance mutations are common in clinical practice?Peter K Cheung, Brian Wynhoven, P Richard Harrigan
AIDS Reviews|September 30, 2008
HIV coreceptor phenotyping in the clinical settingAndrew J Low, Luke C Swenson, P Richard Harrigan
Expert Opinion on Medical Diagnostics|March 15, 2013
Trofile HIV co-receptor usage assayAndrew J Low, Rachel A McGovern, P Richard Harrigan
Pageof 24